Global Artificial Cardiopulmonary Machine Market Research Report 2021

1 Artificial Cardiopulmonary Machine Market Overview

• 1.1 Product Overview and Scope of Artificial Cardiopulmonary Machine
• 1.2 Artificial Cardiopulmonary Machine Segment by Type
  • 1.2.1 Global Artificial Cardiopulmonary Machine Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Single Roller Pump HLM
  • 1.2.3 Double Roller Pump HLM
• 1.3 Artificial Cardiopulmonary Machine Segment by Application
  • 1.3.1 Artificial Cardiopulmonary Machine Sales Comparison by Application: (2021-2027)
  • 1.3.2 Cardiac Surgery
  • 1.3.3 Lung Transplant Operation
  • 1.3.4 Acute Respiratory Failure Treatment
  • 1.3.5 Others
• 1.4 Global Artificial Cardiopulmonary Machine Market Size Estimates and Forecasts
  • 1.4.1 Global Artificial Cardiopulmonary Machine Revenue 2016-2027
  • 1.4.2 Global Artificial Cardiopulmonary Machine Sales 2016-2027
  • 1.4.3 Artificial Cardiopulmonary Machine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Artificial Cardiopulmonary Machine Market Competition by Manufacturers

• 2.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Artificial Cardiopulmonary Machine Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Artificial Cardiopulmonary Machine Manufacturing Sites, Area Served, Product Type
• 2.5 Artificial Cardiopulmonary Machine Market Competitive Situation and Trends
  • 2.5.1 Artificial Cardiopulmonary Machine Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Artificial Cardiopulmonary Machine Players Market Share by Revenue
  • 2.5.3 Global Artificial Cardiopulmonary Machine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artificial Cardiopulmonary Machine Retrospective Market Scenario by Region

• 3.1 Global Artificial Cardiopulmonary Machine Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Artificial Cardiopulmonary Machine Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Artificial Cardiopulmonary Machine Market Facts & Figures by Country
  • 3.3.1 North America Artificial Cardiopulmonary Machine Sales by Country
  • 3.3.2 North America Artificial Cardiopulmonary Machine Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Artificial Cardiopulmonary Machine Market Facts & Figures by Country
  • 3.4.1 Europe Artificial Cardiopulmonary Machine Sales by Country
  • 3.4.2 Europe Artificial Cardiopulmonary Machine Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Artificial Cardiopulmonary Machine Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Artificial Cardiopulmonary Machine Sales by Region
  • 3.5.2 Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Artificial Cardiopulmonary Machine Market Facts & Figures by Country
  • 3.6.1 Latin America Artificial Cardiopulmonary Machine Sales by Country
  • 3.6.2 Latin America Artificial Cardiopulmonary Machine Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Artificial Cardiopulmonary Machine Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Artificial Cardiopulmonary Machine Sales by Country
  • 3.7.2 Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Artificial Cardiopulmonary Machine Historic Market Analysis by Type

• 4.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2016-2021)
• 4.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2016-2021)
• 4.3 Global Artificial Cardiopulmonary Machine Price by Type (2016-2021)

5 Global Artificial Cardiopulmonary Machine Historic Market Analysis by Application

• 5.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2016-2021)
• 5.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2016-2021)
• 5.3 Global Artificial Cardiopulmonary Machine Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 LivaNova (Sorin)
  • 6.1.1 LivaNova (Sorin) Corporation Information
  • 6.1.2 LivaNova (Sorin) Description and Business Overview
  • 6.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 LivaNova (Sorin) Product Portfolio
  • 6.1.5 LivaNova (Sorin) Recent Developments/Updates
• 6.2 Getinge (Maquet)
  • 6.2.1 Getinge (Maquet) Corporation Information
  • 6.2.2 Getinge (Maquet) Description and Business Overview
  • 6.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Getinge (Maquet) Product Portfolio
  • 6.2.5 Getinge (Maquet) Recent Developments/Updates
• 6.3 Medtronic
  • 6.3.1 Medtronic Corporation Information
  • 6.3.2 Medtronic Description and Business Overview
  • 6.3.3 Medtronic Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Medtronic Product Portfolio
  • 6.3.5 Medtronic Recent Developments/Updates
• 6.4 Terumo CV Group
  • 6.4.1 Terumo CV Group Corporation Information
  • 6.4.2 Terumo CV Group Description and Business Overview
  • 6.4.3 Terumo CV Group Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Terumo CV Group Product Portfolio
  • 6.4.5 Terumo CV Group Recent Developments/Updates
• 6.5 Braile Biomedica
  • 6.5.1 Braile Biomedica Corporation Information
  • 6.5.2 Braile Biomedica Description and Business Overview
  • 6.5.3 Braile Biomedica Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Braile Biomedica Product Portfolio
  • 6.5.5 Braile Biomedica Recent Developments/Updates
• 6.6 Tianjin Medical
  • 6.6.1 Tianjin Medical Corporation Information
  • 6.6.2 Tianjin Medical Description and Business Overview
  • 6.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Tianjin Medical Product Portfolio
  • 6.6.5 Tianjin Medical Recent Developments/Updates

7 Artificial Cardiopulmonary Machine Manufacturing Cost Analysis

• 7.1 Artificial Cardiopulmonary Machine Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Artificial Cardiopulmonary Machine
• 7.4 Artificial Cardiopulmonary Machine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Artificial Cardiopulmonary Machine Distributors List
• 8.3 Artificial Cardiopulmonary Machine Customers

9 Artificial Cardiopulmonary Machine Market Dynamics

• 9.1 Artificial Cardiopulmonary Machine Industry Trends
• 9.2 Artificial Cardiopulmonary Machine Growth Drivers
• 9.3 Artificial Cardiopulmonary Machine Market Challenges
• 9.4 Artificial Cardiopulmonary Machine Market Restraints

10 Global Market Forecast

• 10.1 Artificial Cardiopulmonary Machine Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Artificial Cardiopulmonary Machine by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Artificial Cardiopulmonary Machine by Type (2022-2027)
• 10.2 Artificial Cardiopulmonary Machine Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Artificial Cardiopulmonary Machine by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Artificial Cardiopulmonary Machine by Application (2022-2027)
• 10.3 Artificial Cardiopulmonary Machine Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Artificial Cardiopulmonary Machine by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Artificial Cardiopulmonary Machine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List